A diagnostic methodology for Alzheimer's disease.

Area of Science:

• Neuroscience
• Biomedical Engineering
• Computational Biology

Background:

• Alzheimer's disease (AD) diagnosis and therapy remain significant challenges.
• Traditional diagnostic methods rely on historical, behavioral, and psychiatric measures.
• Recent advancements propose a diagnostic framework utilizing biomarkers and imaging.

Purpose of the Study:

• To propose a novel diagnostic methodology for Alzheimer's disease within an advanced diagnostic framework.
• To apply a Support Vector Machine (SVM) based method for identifying crucial AD biomarkers and therapeutic target networks.

Main Methods:

• Utilized an efficient SVM-based method to analyze AD datasets.
• Selected blood-based biomarkers and verified results using cross-validation.
• Constructed AD target networks using mutual information (MI) and hierarchical clustering.

Main Results:

• Identified a small subset of statistically significant blood-based biomarkers for AD.
• Developed an SVM classifier distinguishing AD patients from normal subjects.
• Visualized clustered genes in a heatmap and performed gender-based classification.

Conclusions:

• The machine learning approach effectively identifies relevant AD biomarkers and target networks.
• This methodology aids in differentiating important biomarkers from irrelevant ones for diagnosis and therapy.
• Preliminary gender analysis suggests a potential role for gender in AD diagnosis.